OpenURL Connection Search

Select item for more details and to access through your institution.

Phase II study on first-line treatment of NIVolumab in combination with folfoxiri/bevacizumab in patients with Advanced COloRectal cancer RAS or BRAF mutated - NIVACOR trial (GOIRC-03-2018).
Published in:
2020
By:
- Damato, Angela;
- Iachetta, Francesco;
- Antonuzzo, Lorenzo;
- Nasti, Guglielmo;
- Bergamo, Francesca;
- Bordonaro, Roberto;
- Maiello, Evaristo;
- Zaniboni, Alberto;
- Tonini, Giuseppe;
- Romagnani, Alessandra;
- Berselli, Annalisa;
- Normanno, Nicola;
- Pinto, Carmine
Publication type:
journal article
FOLFOXIRI/Bevacizumab Plus Nivolumab as First-Line Treatment in Metastatic Colorectal Cancer RAS/BRAF Mutated: Safety Run-In of Phase II NIVACOR Trial.
Published in:
Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.766500
By:
- Damato, Angela;
- Bergamo, Francesca;
- Antonuzzo, Lorenzo;
- Nasti, Guglielmo;
- Iachetta, Francesco;
- Romagnani, Alessandra;
- Gervasi, Erika;
- Larocca, Mario;
- Pinto, Carmine
Publication type:
Article
Results of the observational prospective RealFLOT study.
Published in:
2021
By:
- Giommoni, Elisa;
- Lavacchi, Daniele;
- Tirino, Giuseppe;
- Fornaro, Lorenzo;
- Iachetta, Francesco;
- Pozzo, Carmelo;
- Satolli, Maria Antonietta;
- Spallanzani, Andrea;
- Puzzoni, Marco;
- Stragliotto, Silvia;
- Sisani, Michele;
- Formica, Vincenzo;
- Giovanardi, Filippo;
- Strippoli, Antonia;
- Prisciandaro, Michele;
- Di Donato, Samantha;
- Pompella, Luca;
- Pecora, Irene;
- Romagnani, Alessandra;
- Fancelli, Sara
Publication type:
journal article
The clinical relevance of multiple DPYD polymorphisms on patients candidate for fluoropyrimidine based-chemotherapy. An Italian case-control study.
Published in:
2019
By:
- Iachetta, Francesco;
- Bonelli, Candida;
- Romagnani, Alessandra;
- Zamponi, Raffaella;
- Tofani, Lorenzo;
- Farnetti, Enrico;
- Nicoli, Davide;
- Damato, Angela;
- Banzi, Maria;
- Casali, Bruno;
- Pinto, Carmine
Publication type:
journal article
SARS-CoV-2 Positive Hospitalized Cancer Patients during the Italian Outbreak: The Cohort Study in Reggio Emilia.
Published in:
Biology (2079-7737), 2020, v. 9, n. 8, p. 181, doi. 10.3390/biology9080181
By:
- Pinto, Carmine;
- Berselli, Annalisa;
- Mangone, Lucia;
- Damato, Angela;
- Iachetta, Francesco;
- Foracchia, Marco;
- Zanelli, Francesca;
- Gervasi, Erika;
- Romagnani, Alessandra;
- Prati, Giuseppe;
- Lui, Stefania;
- Venturelli, Francesco;
- Vicentini, Massimo;
- Besutti, Giulia;
- De Palma, Rossana;
- Giorgi Rossi, Paolo
Publication type:
Article

Found: 5

Phase II study on first-line treatment of NIVolumab in combination with folfoxiri/bevacizumab in patients with Advanced COloRectal cancer RAS or BRAF mutated - NIVACOR trial (GOIRC-03-2018).

FOLFOXIRI/Bevacizumab Plus Nivolumab as First-Line Treatment in Metastatic Colorectal Cancer RAS/BRAF Mutated: Safety Run-In of Phase II NIVACOR Trial.

Results of the observational prospective RealFLOT study.

The clinical relevance of multiple DPYD polymorphisms on patients candidate for fluoropyrimidine based-chemotherapy. An Italian case-control study.

SARS-CoV-2 Positive Hospitalized Cancer Patients during the Italian Outbreak: The Cohort Study in Reggio Emilia.